[1]
2025. Clinical and Metabolic Determinants of Hepatic Fibrosis in Patients with Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD) – Insights from a Bangladeshi Cohort. The Insight. 8, 03 (Dec. 2025), 588–592. DOI:https://doi.org/10.5281/zenodo.18014065.